îæ€çŽ¢
îæ€çŽ¢
î
NLS Pharmaceutics AG
NLSPWîãŠã©ãããªã¹ãã«è¿œå
0.018USD
0.0000.00%
çµå€Â 05/15, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
0.00æ䟡ç·é¡
--çŽè¿12ã¶æPER
î
詳现æ å ± NLS Pharmaceutics AG äŒæ¥å
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
NLS Pharmaceutics AGã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãNLSPW
äŒç€ŸåNLS Pharmaceutics AG
äžå Žæ¥Jan 29, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Alexander Zwyer
åŸæ¥å¡æ°- -
蚌åžçš®é¡Company Warrant
決ç®ææ«- -
æ¬ç€Ÿæåšå°The Circle 6
éœåžZUERICH
蚌åžååŒæNASDAQ Capital Market Consolidated
åœSwitzerland
éµäŸ¿çªå·8058
é»è©±çªå·41445122150
ãŠã§ããµã€ãhttps://nlspharma.com/
äŒæ¥ã³ãŒãNLSPW
äžå Žæ¥Jan 29, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Alexander Zwyer
NLS Pharmaceutics AGã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
--
--
Mr. Alexander Zwyer
Mr. Alexander Zwyer
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Feb 23, 2025
æŽæ°æå»: Feb 23, 2025
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
9
57.76K
0.00%
-651.13K
2025Q4
9
161.35K
0.00%
-460.28K
2025Q3
8
86.59K
0.00%
-524.31K
2025Q2
9
258.62K
0.00%
-535.48K
2025Q1
9
258.62K
0.00%
-535.48K
2024Q4
9
575.86K
0.00%
+75.79K
2024Q3
10
481.82K
0.00%
-1.36M
2024Q2
12
1.16M
0.00%
-830.95K
2024Q1
11
1.15M
0.00%
-822.65K
2023Q4
10
1.13M
0.00%
-839.40K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Wolverine Asset Management, LLC
--
0%
-245.00K
-100.00%
Mar 31, 2025
Hudson Bay Capital Management LP
--
0%
-71.36K
-100.00%
Mar 31, 2025
Clear Street LLC
57.76K
0%
+120.00
+0.21%
Jun 30, 2025
Citadel Advisors LLC
--
0%
-18.38K
-100.00%
Jun 30, 2025
Altium Capital Management LP
--
0%
-200.00K
-100.00%
Dec 31, 2024
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
